What is Outpace Bio worth?
$220.0Mlast known valuation
Outpace Bio last raised $144.0M in its Early Stage VC (Series B) (Jul 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Outpace Bio
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jul 2024 | Early Stage VC (Series B) | $144.0M | ▮ | ▮ |
How Outpace Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Outpace Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Outpace Bio worth?
- Outpace Bio's last known valuation is $220.0M.
- How much has Outpace Bio raised?
- Outpace Bio has raised $199.0M in total funding across 1 recorded rounds.
- When did Outpace Bio last raise?
- Outpace Bio last raised in Jul 2024 (Early Stage VC (Series B)), raising $144.0M.